EDGAR Filing Documents for 0001615774-14-000295

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

SEC Accession No. 0001615774-14-000295

Filing Date

2014-11-12

Accepted

2014-11-12 15:58:46

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-1/A	s100441_s1.htm	S-1/A	1715214
2	EX-4.1	s100441_ex4-1.htm	EX-4.1	18525
3	EX-4.2	s100441_ex4-2.htm	EX-4.2	17325
4	EX-4.3	s100441_ex4-3.htm	EX-4.3	17707
5	EX-4.4	s100441_ex4-4.htm	EX-4.4	19392
6	EXHIBIT 4.5	s100441_ex4-5.htm	EX-4.5	53532
7	EXHIBIT 4.6	s100441_ex4-6.htm	EX-4.6	96306
8	EXHIBIT 10.1	s100441_ex10-1.htm	EX-10.1	42420
9	EXHIBIT 10.2	s100441_ex10-2.htm	EX-10	87909
10	EX-10.3	s100441_ex10-3.htm	EX-10.3	47589
11	EXHIBIT 10.4	s100441_ex10-4.htm	EX-10.4	6895
12	EXHIBIT 10.6	s100441_ex10-6.htm	EX-10.6	101771
13	EXHIBIT 10.7	s100441_ex10-7.htm	EX-10.7	22229
14	EXHIBIT 10.8	s100441_ex10-8.htm	EX-10.8	23829
15	EX-14	s100441_ex14.htm	EX-14	31884
16	EXHIBIT 23.1	s100441_ex23-1.htm	EX-23.1	2879
17	EX-99.1	s100441_ex99-1.htm	EX-99.1	28219
18	EX-99.2	s100441_ex99-2.htm	EX-99.2	29403
19	EX-99.3	s100441_ex99-3.htm	EX-99.3	21413
20		filename20.htm	CORRESP	48007
	Complete submission text file	0001615774-14-000295.txt		2433507

Mailing Address 24 NEW ENGLAND EXECUTIVE PARK SUITE 105 BURLINGTON MA 01803

Business Address 24 NEW ENGLAND EXECUTIVE PARK SUITE 105 BURLINGTON MA 01803 781-652-4500

CB Pharma Acquisition Corp. (Filer) CIK: 0001619551 (see all company filings)